$TTPH Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in TETRAPHASE PHARMACEUTICALS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in TETRAPHASE PHARMACEUTICALS INC. Get notifications about new insider transactions in TETRAPHASE PHARMACEUTICALS INC for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jul 30 2020 | TTPH | TETRAPHASE PHARMAC ... | ARMISTICE CAPITAL, LLC | Director | Option Exercise | J | 2.87 | 3,333,334 | 9,566,669 | 0 | |
Jul 30 2020 | TTPH | TETRAPHASE PHARMAC ... | ARMISTICE CAPITAL, LLC | Director | Option Exercise | J | 3.62 | 2,130,493 | 7,712,385 | 0 | |
Jul 30 2020 | TTPH | TETRAPHASE PHARMAC ... | ARMISTICE CAPITAL, LLC | Director | Option Exercise | J | 0.00 | 2,063,334 | 2,063 | 0 | |
Jul 30 2020 | TTPH | TETRAPHASE PHARMAC ... | ARMISTICE CAPITAL, LLC | Director | Option Exercise | J | 0.01 | 1,430,493 | 14,305 | 0 | |
Jul 30 2020 | TTPH | TETRAPHASE PHARMAC ... | ARMISTICE CAPITAL, LLC | Director | Sell | J | 0.00 | 1,419,507 | 0 | 0 | 1.4 M to 0 (-100.00 %) |
Jul 29 2020 | TTPH | TETRAPHASE PHARMAC ... | LA JOLLA PHARMACEUTICAL CO | 10% Owner | Buy | P | 2.00 | 3,737,360 | 7,474,720 | 4,822,360 | 1.1 M to 4.8 M (+344.46 %) |
Jul 29 2020 | TTPH | TETRAPHASE PHARMAC ... | Watt Christopher | Senior Vice Preside ... | Option Exercise | D | 0.00 | 55 | 0 | 0 | |
Jul 29 2020 | TTPH | TETRAPHASE PHARMAC ... | Watt Christopher | Senior Vice Preside ... | Option Exercise | D | 0.00 | 3,515 | 0 | 0 | |
Jul 29 2020 | TTPH | TETRAPHASE PHARMAC ... | Watt Christopher | Senior Vice Preside ... | Option Exercise | D | 0.00 | 1,044 | 0 | 0 | |
Jul 29 2020 | TTPH | TETRAPHASE PHARMAC ... | Watt Christopher | Senior Vice Preside ... | Option Exercise | D | 0.00 | 389 | 0 | 0 | |
Jul 29 2020 | TTPH | TETRAPHASE PHARMAC ... | Watt Christopher | Senior Vice Preside ... | Option Exercise | D | 0.00 | 467 | 0 | 0 | |
Jul 29 2020 | TTPH | TETRAPHASE PHARMAC ... | Watt Christopher | Senior Vice Preside ... | Sell | U | 0.00 | 769 | 0 | 0 | 769 to 0 (-100.00 %) |
Jul 29 2020 | TTPH | TETRAPHASE PHARMAC ... | Edwards Larry G. | See Remarks | Option Exercise | D | 0.00 | 1,875 | 0 | 0 | |
Jul 29 2020 | TTPH | TETRAPHASE PHARMAC ... | Edwards Larry G. | See Remarks | Option Exercise | D | 0.00 | 2,025 | 0 | 0 | |
Jul 29 2020 | TTPH | TETRAPHASE PHARMAC ... | Edwards Larry G. | See Remarks | Option Exercise | D | 0.00 | 640 | 0 | 0 | |
Jul 29 2020 | TTPH | TETRAPHASE PHARMAC ... | Edwards Larry G. | See Remarks | Option Exercise | D | 0.00 | 7,500 | 0 | 0 | |
Jul 29 2020 | TTPH | TETRAPHASE PHARMAC ... | Edwards Larry G. | See Remarks | Option Exercise | D | 0.00 | 6,595 | 0 | 0 | |
Jul 29 2020 | TTPH | TETRAPHASE PHARMAC ... | Edwards Larry G. | See Remarks | Option Exercise | D | 0.00 | 1,374 | 0 | 0 | |
Jul 29 2020 | TTPH | TETRAPHASE PHARMAC ... | Edwards Larry G. | See Remarks | Option Exercise | D | 0.00 | 623 | 0 | 0 | |
Jul 29 2020 | TTPH | TETRAPHASE PHARMAC ... | Edwards Larry G. | See Remarks | Sell | U | 0.00 | 1,346 | 0 | 0 | 1.3 K to 0 (-100.00 %) |
Jul 29 2020 | TTPH | TETRAPHASE PHARMAC ... | Macdonald Guy | Director | Sell | U | 0.00 | 15,703 | 0 | 0 | 15.7 K to 0 (-100.00 %) |
Jul 29 2020 | TTPH | TETRAPHASE PHARMAC ... | GAGE L PATRICK | Director | Sell | U | 0.00 | 191 | 0 | 0 | 191 to 0 (-100.00 %) |
Jul 29 2020 | TTPH | TETRAPHASE PHARMAC ... | GAGE L PATRICK | Director | Sell | U | 0.00 | 1,944 | 0 | 0 | 1.9 K to 0 (-100.00 %) |
Jul 29 2020 | TTPH | TETRAPHASE PHARMAC ... | Stahl Maria D | See Remarks | Option Exercise | D | 0.00 | 675 | 0 | 0 | |
Jul 29 2020 | TTPH | TETRAPHASE PHARMAC ... | Stahl Maria D | See Remarks | Option Exercise | D | 0.00 | 1,800 | 0 | 0 | |
Jul 29 2020 | TTPH | TETRAPHASE PHARMAC ... | Stahl Maria D | See Remarks | Option Exercise | D | 0.00 | 640 | 0 | 0 | |
Jul 29 2020 | TTPH | TETRAPHASE PHARMAC ... | Stahl Maria D | See Remarks | Option Exercise | D | 0.00 | 335 | 0 | 0 | |
Jul 29 2020 | TTPH | TETRAPHASE PHARMAC ... | Stahl Maria D | See Remarks | Option Exercise | D | 0.00 | 2,850 | 0 | 0 | |
Jul 29 2020 | TTPH | TETRAPHASE PHARMAC ... | Stahl Maria D | See Remarks | Option Exercise | D | 0.00 | 6,156 | 0 | 0 | |
Jul 29 2020 | TTPH | TETRAPHASE PHARMAC ... | Stahl Maria D | See Remarks | Option Exercise | D | 0.00 | 1,382 | 0 | 0 | |
Jul 29 2020 | TTPH | TETRAPHASE PHARMAC ... | Stahl Maria D | See Remarks | Option Exercise | D | 0.00 | 934 | 0 | 0 | |
Jul 29 2020 | TTPH | TETRAPHASE PHARMAC ... | Stahl Maria D | See Remarks | Sell | U | 0.00 | 250 | 0 | 0 | 250 to 0 (-100.00 %) |
Jun 22 2020 | TTPH | TETRAPHASE PHARMAC ... | LA JOLLA PHARMACEUTICAL CO | 10% Owner | Buy | P | 2.62 | 234,698 | 613,993 | 1,085,000 | 850.3 K to 1.1 M (+27.60 %) |
Dec 12 2019 | TTPH | TETRAPHASE PHARMAC ... | Freund John Gordon | Director | Sell | S | 2.19 | 524 | 1,148 | 0 | 524 to 0 (-100.00 %) |
Dec 12 2019 | TTPH | TETRAPHASE PHARMAC ... | Freund John Gordon | Director | Sell | S | 2.19 | 524 | 1,148 | 0 | 524 to 0 (-100.00 %) |
Dec 12 2019 | TTPH | TETRAPHASE PHARMAC ... | Freund John Gordon | Director | Sell | S | 2.19 | 14,507 | 31,770 | 0 | 14.5 K to 0 (-100.00 %) |
Dec 12 2019 | TTPH | TETRAPHASE PHARMAC ... | Freund John Gordon | Director | Sell | S | 2.19 | 14,507 | 31,770 | 0 | 14.5 K to 0 (-100.00 %) |
Dec 09 2019 | TTPH | TETRAPHASE PHARMAC ... | Macdonald Guy | Director | Sell | S | 2.25 | 5,735 | 12,904 | 250 | 6 K to 250 (-95.82 %) |
Dec 09 2019 | TTPH | TETRAPHASE PHARMAC ... | Macdonald Guy | Director | Sell | S | 2.34 | 1,870 | 4,376 | 5,985 | 7.9 K to 6 K (-23.81 %) |
Aug 02 2019 | TTPH | TETRAPHASE PHARMAC ... | Stahl Maria D | CBO and General Cou ... | Option Exercise | A | 0.00 | 57,000 | 0 | 57,000 | |
Aug 02 2019 | TTPH | TETRAPHASE PHARMAC ... | Stahl Maria D | CBO and General Cou ... | Option Exercise | A | 0.00 | 18,000 | 0 | 18,000 | |
Aug 02 2019 | TTPH | TETRAPHASE PHARMAC ... | Stahl Maria D | CBO and General Cou ... | Grant | A | 0.00 | 13,913 | 0 | 37,611 | 23.7 K to 37.6 K (+58.71 %) |
Aug 02 2019 | TTPH | TETRAPHASE PHARMAC ... | Edwards Larry G. | President and CEO | Option Exercise | A | 0.00 | 150,000 | 0 | 150,000 | |
Aug 02 2019 | TTPH | TETRAPHASE PHARMAC ... | Edwards Larry G. | President and CEO | Option Exercise | A | 0.00 | 50,000 | 0 | 50,000 | |
Aug 02 2019 | TTPH | TETRAPHASE PHARMAC ... | Edwards Larry G. | President and CEO | Grant | A | 0.00 | 4,148 | 0 | 54,937 | 50.8 K to 54.9 K (+8.17 %) |
Aug 02 2019 | TTPH | TETRAPHASE PHARMAC ... | Edwards Larry G. | President and CEO | Grant | A | 0.00 | 13,913 | 0 | 50,789 | 36.9 K to 50.8 K (+37.73 %) |
Jun 11 2019 | TTPH | TETRAPHASE PHARMAC ... | Wysenski Nancy | Director | Option Exercise | A | 0.77 | 16,500 | 12,705 | 16,500 | |
Jun 11 2019 | TTPH | TETRAPHASE PHARMAC ... | HENWOOD GERALDINE | Director | Option Exercise | A | 0.77 | 16,500 | 12,705 | 16,500 | |
Jun 11 2019 | TTPH | TETRAPHASE PHARMAC ... | GAGE L PATRICK | Director | Option Exercise | A | 0.77 | 16,500 | 12,705 | 16,500 | |
Jun 11 2019 | TTPH | TETRAPHASE PHARMAC ... | Freund John Gordon | Director | Option Exercise | A | 0.77 | 16,500 | 12,705 | 16,500 | |
Jun 11 2019 | TTPH | TETRAPHASE PHARMAC ... | Chodakewitz Jeffrey | Director | Option Exercise | A | 0.77 | 16,500 | 12,705 | 16,500 | |
Jun 11 2019 | TTPH | TETRAPHASE PHARMAC ... | BOHLIN GAREN G | Director | Option Exercise | A | 0.77 | 16,500 | 12,705 | 16,500 | |
Jan 18 2019 | TTPH | TETRAPHASE PHARMAC ... | Watt Christopher | SVP, Finance | Option Exercise | A | 0.00 | 80,000 | 0 | 80,000 | |
Jan 18 2019 | TTPH | TETRAPHASE PHARMAC ... | Watt Christopher | SVP, Finance | Grant | A | 0.00 | 3,332 | 0 | 27,172 | 23.8 K to 27.2 K (+13.98 %) |
Jan 18 2019 | TTPH | TETRAPHASE PHARMAC ... | Watt Christopher | SVP, Finance | Grant | A | 0.00 | 2,058 | 0 | 23,840 | 21.8 K to 23.8 K (+9.45 %) |
Jan 18 2019 | TTPH | TETRAPHASE PHARMAC ... | Watt Christopher | SVP, Finance | Grant | A | 0.00 | 2,668 | 0 | 21,782 | 19.1 K to 21.8 K (+13.96 %) |
Jan 18 2019 | TTPH | TETRAPHASE PHARMAC ... | Tsai Larry | Chief Medical Offic ... | Option Exercise | A | 0.00 | 140,000 | 0 | 140,000 | |
Jan 18 2019 | TTPH | TETRAPHASE PHARMAC ... | Tsai Larry | Chief Medical Offic ... | Option Exercise | A | 0.00 | 40,000 | 0 | 40,000 | |
Jan 18 2019 | TTPH | TETRAPHASE PHARMAC ... | Tsai Larry | Chief Medical Offic ... | Grant | A | 0.00 | 2,058 | 0 | 33,561 | 31.5 K to 33.6 K (+6.53 %) |
Jan 18 2019 | TTPH | TETRAPHASE PHARMAC ... | Tsai Larry | Chief Medical Offic ... | Grant | A | 0.00 | 3,337 | 0 | 31,503 | 28.2 K to 31.5 K (+11.85 %) |
Jan 18 2019 | TTPH | TETRAPHASE PHARMAC ... | Stahl Maria D | SVP and General Cou ... | Option Exercise | A | 0.00 | 140,000 | 0 | 140,000 | |
Jan 18 2019 | TTPH | TETRAPHASE PHARMAC ... | Stahl Maria D | SVP and General Cou ... | Option Exercise | A | 0.00 | 40,000 | 0 | 40,000 | |
Jan 18 2019 | TTPH | TETRAPHASE PHARMAC ... | Stahl Maria D | SVP and General Cou ... | Grant | A | 0.00 | 18,698 | 0 | 23,698 | 5 K to 23.7 K (+373.96 %) |
Jan 18 2019 | TTPH | TETRAPHASE PHARMAC ... | Macdonald Guy | President and Chief ... | Option Exercise | A | 0.00 | 300,000 | 0 | 300,000 | |
Jan 18 2019 | TTPH | TETRAPHASE PHARMAC ... | Macdonald Guy | President and Chief ... | Option Exercise | A | 0.00 | 100,000 | 0 | 100,000 | |
Jan 18 2019 | TTPH | TETRAPHASE PHARMAC ... | Macdonald Guy | President and Chief ... | Grant | A | 0.00 | 3,332 | 0 | 134,396 | 131.1 K to 134.4 K (+2.54 %) |
Jan 18 2019 | TTPH | TETRAPHASE PHARMAC ... | Macdonald Guy | President and Chief ... | Grant | A | 0.00 | 2,058 | 0 | 131,064 | 129 K to 131.1 K (+1.60 %) |
Jan 18 2019 | TTPH | TETRAPHASE PHARMAC ... | Edwards Larry G. | Chief Operating Off ... | Option Exercise | A | 0.00 | 150,000 | 0 | 150,000 | |
Jan 18 2019 | TTPH | TETRAPHASE PHARMAC ... | Edwards Larry G. | Chief Operating Off ... | Option Exercise | A | 0.00 | 45,000 | 0 | 45,000 | |
Jan 18 2019 | TTPH | TETRAPHASE PHARMAC ... | Edwards Larry G. | Chief Operating Off ... | Grant | A | 0.00 | 2,509 | 0 | 36,876 | 34.4 K to 36.9 K (+7.30 %) |
Jan 18 2019 | TTPH | TETRAPHASE PHARMAC ... | Edwards Larry G. | Chief Operating Off ... | Grant | A | 0.00 | 2,058 | 0 | 34,367 | 32.3 K to 34.4 K (+6.37 %) |
Jan 18 2019 | TTPH | TETRAPHASE PHARMAC ... | Edwards Larry G. | Chief Operating Off ... | Grant | A | 0.00 | 4,277 | 0 | 32,309 | 28 K to 32.3 K (+15.26 %) |
Jan 18 2019 | TTPH | TETRAPHASE PHARMAC ... | Dumas Jacques | Chief ScientificOff ... | Option Exercise | A | 0.00 | 140,000 | 0 | 140,000 | |
Jan 18 2019 | TTPH | TETRAPHASE PHARMAC ... | Dumas Jacques | Chief ScientificOff ... | Option Exercise | A | 0.00 | 40,000 | 0 | 40,000 | |
Jan 10 2019 | TTPH | TETRAPHASE PHARMAC ... | Dumas Jacques | Chief ScientificOff ... | Sell | S | 1.60 | 7,497 | 11,995 | 0 | 7.5 K to 0 (-100.00 %) |
Jun 01 2018 | TTPH | TETRAPHASE PHARMAC ... | Wysenski Nancy | Director | Option Exercise | A | 3.68 | 12,500 | 46,000 | 12,500 | |
Jun 01 2018 | TTPH | TETRAPHASE PHARMAC ... | HENWOOD GERALDINE | Director | Option Exercise | A | 3.68 | 12,500 | 46,000 | 12,500 | |
Jun 01 2018 | TTPH | TETRAPHASE PHARMAC ... | GAGE L PATRICK | Director | Option Exercise | A | 3.68 | 12,500 | 46,000 | 12,500 | |
Jun 01 2018 | TTPH | TETRAPHASE PHARMAC ... | Chodakewitz Jeffrey | Director | Option Exercise | A | 3.68 | 12,500 | 46,000 | 12,500 | |
Jun 01 2018 | TTPH | TETRAPHASE PHARMAC ... | BOHLIN GAREN G | Director | Option Exercise | A | 3.68 | 12,500 | 46,000 | 12,500 | |
Apr 04 2018 | TTPH | TETRAPHASE PHARMAC ... | Watt Christopher | SVP, Finance | Option Exercise | A | 0.00 | 30,000 | 0 | 30,000 | |
Apr 04 2018 | TTPH | TETRAPHASE PHARMAC ... | Tsai Larry | Chief Medical Offic ... | Option Exercise | A | 0.00 | 40,000 | 0 | 40,000 | |
Apr 04 2018 | TTPH | TETRAPHASE PHARMAC ... | Stahl Maria D | SVP and General Cou ... | Option Exercise | A | 0.00 | 40,000 | 0 | 40,000 | |
Apr 04 2018 | TTPH | TETRAPHASE PHARMAC ... | Macdonald Guy | President and Chief ... | Option Exercise | A | 0.00 | 50,000 | 0 | 50,000 | |
Apr 04 2018 | TTPH | TETRAPHASE PHARMAC ... | Edwards Larry G. | Chief Operating Off ... | Option Exercise | A | 0.00 | 40,000 | 0 | 40,000 | |
Apr 04 2018 | TTPH | TETRAPHASE PHARMAC ... | Dumas Jacques | Chief ScientificOff ... | Option Exercise | A | 0.00 | 40,000 | 0 | 40,000 | |
Jan 31 2018 | TTPH | TETRAPHASE PHARMAC ... | Dumas Jacques | Chief ScientificOff ... | Option Exercise | M | 3.69 | 8,750 | 32,288 | 105,000 | |
Jan 31 2018 | TTPH | TETRAPHASE PHARMAC ... | Dumas Jacques | Chief ScientificOff ... | Sell | S | 6.22 | 8,750 | 54,425 | 0 | 8.8 K to 0 (-100.00 %) |
Jan 31 2018 | TTPH | TETRAPHASE PHARMAC ... | Dumas Jacques | Chief ScientificOff ... | Buy | M | 3.69 | 8,750 | 32,288 | 8,750 | 0 to 8.8 K |
Jan 19 2018 | TTPH | TETRAPHASE PHARMAC ... | Unninayar Kamalam | Chief Financial Off ... | Option Exercise | A | 0.00 | 40,000 | 0 | 40,000 | |
Jan 19 2018 | TTPH | TETRAPHASE PHARMAC ... | Tsai Larry | Chief Medical Offic ... | Option Exercise | A | 6.24 | 150,000 | 936,000 | 150,000 | |
Jan 19 2018 | TTPH | TETRAPHASE PHARMAC ... | Tsai Larry | Chief Medical Offic ... | Option Exercise | A | 0.00 | 40,000 | 0 | 40,000 | |
Jan 19 2018 | TTPH | TETRAPHASE PHARMAC ... | Stahl Maria D | SVP and General Cou ... | Option Exercise | A | 6.24 | 115,000 | 717,600 | 115,000 | |
Jan 19 2018 | TTPH | TETRAPHASE PHARMAC ... | Stahl Maria D | SVP and General Cou ... | Option Exercise | A | 0.00 | 32,000 | 0 | 32,000 | |
Jan 19 2018 | TTPH | TETRAPHASE PHARMAC ... | Macdonald Guy | President and Chief ... | Option Exercise | A | 6.34 | 300,000 | 1,902,000 | 300,000 | |
Jan 19 2018 | TTPH | TETRAPHASE PHARMAC ... | Macdonald Guy | President and Chief ... | Option Exercise | A | 0.00 | 100,000 | 0 | 100,000 | |
Jan 19 2018 | TTPH | TETRAPHASE PHARMAC ... | Macdonald Guy | President and Chief ... | Grant | A | 0.00 | 1,566 | 0 | 129,006 | 127.4 K to 129 K (+1.23 %) |
Jan 19 2018 | TTPH | TETRAPHASE PHARMAC ... | Macdonald Guy | President and Chief ... | Grant | A | 0.00 | 3,101 | 0 | 127,440 | 124.3 K to 127.4 K (+2.49 %) |
Jan 19 2018 | TTPH | TETRAPHASE PHARMAC ... | Dumas Jacques | Chief ScientificOff ... | Option Exercise | A | 6.24 | 140,000 | 873,600 | 140,000 | |
Jan 19 2018 | TTPH | TETRAPHASE PHARMAC ... | Dumas Jacques | Chief ScientificOff ... | Option Exercise | A | 0.00 | 40,000 | 0 | 40,000 | |
Jan 19 2018 | TTPH | TETRAPHASE PHARMAC ... | Unninayar Kamalam | Chief Financial Off ... | Option Exercise | A | 0.00 | 40,000 | 0 | 40,000 | |
Jan 19 2018 | TTPH | TETRAPHASE PHARMAC ... | Tsai Larry | Chief Medical Offic ... | Option Exercise | A | 6.24 | 150,000 | 936,000 | 150,000 | |
Jan 19 2018 | TTPH | TETRAPHASE PHARMAC ... | Tsai Larry | Chief Medical Offic ... | Option Exercise | A | 0.00 | 40,000 | 0 | 40,000 | |
Jan 19 2018 | TTPH | TETRAPHASE PHARMAC ... | Stahl Maria D | SVP and General Cou ... | Option Exercise | A | 6.24 | 115,000 | 717,600 | 115,000 | |
Jan 19 2018 | TTPH | TETRAPHASE PHARMAC ... | Stahl Maria D | SVP and General Cou ... | Option Exercise | A | 0.00 | 32,000 | 0 | 32,000 | |
Jan 19 2018 | TTPH | TETRAPHASE PHARMAC ... | Macdonald Guy | President and Chief ... | Option Exercise | A | 6.34 | 300,000 | 1,902,000 | 300,000 | |
Jan 19 2018 | TTPH | TETRAPHASE PHARMAC ... | Macdonald Guy | President and Chief ... | Option Exercise | A | 0.00 | 100,000 | 0 | 100,000 | |
Jan 19 2018 | TTPH | TETRAPHASE PHARMAC ... | Macdonald Guy | President and Chief ... | Grant | A | 0.00 | 1,566 | 0 | 129,006 | 127.4 K to 129 K (+1.23 %) |
Jan 19 2018 | TTPH | TETRAPHASE PHARMAC ... | Macdonald Guy | President and Chief ... | Grant | A | 0.00 | 3,101 | 0 | 127,440 | 124.3 K to 127.4 K (+2.49 %) |
Jan 19 2018 | TTPH | TETRAPHASE PHARMAC ... | Dumas Jacques | Chief ScientificOff ... | Option Exercise | A | 6.24 | 140,000 | 873,600 | 140,000 | |
Jan 19 2018 | TTPH | TETRAPHASE PHARMAC ... | Dumas Jacques | Chief ScientificOff ... | Option Exercise | A | 0.00 | 40,000 | 0 | 40,000 | |
Jan 11 2018 | TTPH | TETRAPHASE PHARMAC ... | Dumas Jacques | Chief ScientificOff ... | Sell | S | 6.21 | 7,167 | 44,507 | 0 | 7.2 K to 0 (-100.00 %) |
Dec 04 2017 | TTPH | TETRAPHASE PHARMAC ... | GAGE L PATRICK | Director | Buy | P | 6.45 | 3,880 | 25,026 | 38,880 | 35 K to 38.9 K (+11.09 %) |
Nov 15 2017 | TTPH | TETRAPHASE PHARMAC ... | Unninayar Kamalam | Chief Financial Off ... | Option Exercise | A | 6.07 | 190,000 | 1,153,300 | 190,000 | |
Nov 02 2017 | TTPH | TETRAPHASE PHARMAC ... | Dumas Jacques | Chief ScientificOff ... | Option Exercise | M | 3.69 | 8,750 | 32,288 | 113,750 | |
Nov 02 2017 | TTPH | TETRAPHASE PHARMAC ... | Dumas Jacques | Chief ScientificOff ... | Sell | S | 6.03 | 8,750 | 52,763 | 0 | 8.8 K to 0 (-100.00 %) |
Nov 02 2017 | TTPH | TETRAPHASE PHARMAC ... | Dumas Jacques | Chief ScientificOff ... | Buy | M | 3.69 | 8,750 | 32,288 | 8,750 | 0 to 8.8 K |
Aug 24 2017 | TTPH | TETRAPHASE PHARMAC ... | Dumas Jacques | Chief ScientificOff ... | Option Exercise | M | 3.69 | 17,500 | 64,575 | 122,500 | |
Aug 24 2017 | TTPH | TETRAPHASE PHARMAC ... | Dumas Jacques | Chief ScientificOff ... | Sell | S | 6.00 | 17,500 | 105,000 | 0 | 17.5 K to 0 (-100.00 %) |
Aug 24 2017 | TTPH | TETRAPHASE PHARMAC ... | Dumas Jacques | Chief ScientificOff ... | Buy | M | 3.69 | 17,500 | 64,575 | 17,500 | 0 to 17.5 K |
Aug 21 2017 | TTPH | TETRAPHASE PHARMAC ... | Dumas Jacques | Chief ScientificOff ... | Sell | S | 5.86 | 7,155 | 41,928 | 0 | 7.2 K to 0 (-100.00 %) |
Jun 14 2017 | TTPH | TETRAPHASE PHARMAC ... | Horn Patrick Taylor | Chief Medical Offic ... | Option Exercise | M | 2.03 | 10,000 | 20,300 | 47,689 | |
Jun 14 2017 | TTPH | TETRAPHASE PHARMAC ... | Horn Patrick Taylor | Chief Medical Offic ... | Buy | M | 2.03 | 10,000 | 20,300 | 10,000 | 0 to 10 K |
Jun 01 2017 | TTPH | TETRAPHASE PHARMAC ... | Wysenski Nancy | Director | Option Exercise | A | 6.89 | 12,500 | 86,125 | 12,500 | |
Jun 01 2017 | TTPH | TETRAPHASE PHARMAC ... | HENWOOD GERALDINE | Director | Option Exercise | A | 6.89 | 12,500 | 86,125 | 12,500 | |
Jun 01 2017 | TTPH | TETRAPHASE PHARMAC ... | GAGE L PATRICK | Director | Option Exercise | A | 6.89 | 12,500 | 86,125 | 12,500 | |
Jun 01 2017 | TTPH | TETRAPHASE PHARMAC ... | Freund John Gordon | Director | Option Exercise | A | 6.89 | 12,500 | 86,125 | 12,500 | |
Jun 01 2017 | TTPH | TETRAPHASE PHARMAC ... | Chodakewitz Jeffrey | Director | Option Exercise | A | 6.89 | 12,500 | 86,125 | 12,500 | |
Jun 01 2017 | TTPH | TETRAPHASE PHARMAC ... | BOHLIN GAREN G | Director | Option Exercise | A | 6.89 | 12,500 | 86,125 | 12,500 | |
Mar 16 2017 | TTPH | TETRAPHASE PHARMAC ... | GAGE L PATRICK | Director | Buy | P | 7.47 | 1,000 | 7,470 | 3,825 | 2.8 K to 3.8 K (+35.40 %) |
Mar 16 2017 | TTPH | TETRAPHASE PHARMAC ... | GAGE L PATRICK | Director | Buy | P | 7.49 | 10,000 | 74,900 | 35,000 | 25 K to 35 K (+40.00 %) |
Feb 13 2017 | TTPH | TETRAPHASE PHARMAC ... | Macdonald Guy | President and Chief ... | Option Exercise | M | 2.90 | 30,378 | 88,096 | 0 | |
Feb 13 2017 | TTPH | TETRAPHASE PHARMAC ... | Macdonald Guy | President and Chief ... | Buy | M | 2.90 | 30,378 | 88,096 | 124,339 | 94 K to 124.3 K (+32.33 %) |
Feb 01 2017 | TTPH | TETRAPHASE PHARMAC ... | Watt Christopher | SVP, Finance | Option Exercise | A | 3.69 | 60,000 | 221,400 | 60,000 | |
Feb 01 2017 | TTPH | TETRAPHASE PHARMAC ... | Watt Christopher | SVP, Finance | Option Exercise | A | 0.00 | 15,000 | 0 | 15,000 | |
Feb 01 2017 | TTPH | TETRAPHASE PHARMAC ... | Stahl Maria D | SVP and General Cou ... | Option Exercise | A | 3.69 | 115,000 | 424,350 | 115,000 | |
Feb 01 2017 | TTPH | TETRAPHASE PHARMAC ... | Stahl Maria D | SVP and General Cou ... | Option Exercise | A | 0.00 | 25,000 | 0 | 25,000 | |
Feb 01 2017 | TTPH | TETRAPHASE PHARMAC ... | Macdonald Guy | President and Chief ... | Option Exercise | A | 3.83 | 300,000 | 1,149,000 | 300,000 | |
Feb 01 2017 | TTPH | TETRAPHASE PHARMAC ... | Macdonald Guy | President and Chief ... | Option Exercise | A | 0.00 | 75,000 | 0 | 75,000 | |
Feb 01 2017 | TTPH | TETRAPHASE PHARMAC ... | Macdonald Guy | President and Chief ... | Grant | A | 0.00 | 3,204 | 0 | 93,961 | 90.8 K to 94 K (+3.53 %) |
Feb 01 2017 | TTPH | TETRAPHASE PHARMAC ... | Horn Patrick Taylor | Chief Medical Offic ... | Option Exercise | A | 3.69 | 140,000 | 516,600 | 140,000 | |
Feb 01 2017 | TTPH | TETRAPHASE PHARMAC ... | Horn Patrick Taylor | Chief Medical Offic ... | Option Exercise | A | 0.00 | 30,000 | 0 | 30,000 | |
Feb 01 2017 | TTPH | TETRAPHASE PHARMAC ... | Dumas Jacques | Chief ScientificOff ... | Option Exercise | A | 3.69 | 140,000 | 516,600 | 140,000 | |
Feb 01 2017 | TTPH | TETRAPHASE PHARMAC ... | Dumas Jacques | Chief ScientificOff ... | Option Exercise | A | 0.00 | 30,000 | 0 | 30,000 | |
Jun 10 2016 | TTPH | TETRAPHASE PHARMAC ... | Wysenski Nancy | Director | Option Exercise | A | 4.27 | 10,000 | 42,700 | 10,000 | |
Jun 10 2016 | TTPH | TETRAPHASE PHARMAC ... | HENWOOD GERALDINE | Director | Option Exercise | A | 4.27 | 10,000 | 42,700 | 10,000 | |
Jun 10 2016 | TTPH | TETRAPHASE PHARMAC ... | GAGE L PATRICK | Director | Option Exercise | A | 4.27 | 10,000 | 42,700 | 10,000 | |
Jun 10 2016 | TTPH | TETRAPHASE PHARMAC ... | Freund John Gordon | Director | Option Exercise | A | 4.27 | 10,000 | 42,700 | 10,000 | |
Jun 10 2016 | TTPH | TETRAPHASE PHARMAC ... | Chodakewitz Jeffrey | Director | Option Exercise | A | 4.27 | 10,000 | 42,700 | 10,000 | |
Jun 10 2016 | TTPH | TETRAPHASE PHARMAC ... | BOHLIN GAREN G | Director | Option Exercise | A | 4.27 | 10,000 | 42,700 | 10,000 |